Sagimet Biosciences Presents Clinical Denifanstat and Preclinical FASN Inhibitor Data at AASLD

SAN MATEO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) — Sagimet … California San Diego, the primary investigator of the FASCINATE-2 trial.

Continue

Do you trust this headline?

Based on recent headline ratings, 82% of this readership currently trusts the local media, which has an average score of 82% regionally and is currently trending positiveneutrally.

82%

Media Trust Score82%

Read All

In

News